Mylan Strikes $4.5M Deal With Maryland Over EpiPen Pricing
By Gina Kim · May 5, 2026, 8:35 PM EDT
Mylan Pharmaceuticals will pay $4.5 million to resolve allegations by the state of Maryland that Mylan acted anticompetitively when it ratcheted up costs of its portable auto-injectable EpiPen device that's used...
To view the full article, register now.